首页> 外文期刊>U. S. pharmacist >Updated Clinical Practice Guidelines for Community-Acquired Pneumonia
【24h】

Updated Clinical Practice Guidelines for Community-Acquired Pneumonia

机译:更新了社区获得的肺炎的临床实践指南

获取原文
获取原文并翻译 | 示例
       

摘要

In 2019, guidelines for the management of immunocompetent adults with community-acquired pneumonia (CAP) were published jointly by the American Thoracic Society and the Infectious Diseases Society of America. Different treatment regimens are recommended depending on whether the patient is receiving treatment in the inpatient or outpatient setting, the severity of the pneumonia, and whether the patient has comorbidities or any risk factors for drug-resistant pathogens.The recommended duration of antimicrobial treatment for patients with CAP is a minimum of 5 days. Pharmacists should work actively with physicians to recommend appropriate antimicrobial therapy for the treatment of patients with CAP and are in a key position to ensure that patients receive the appropriate duration of therapy.
机译:2019年,美国胸部社会和美国传染病学会共同出版了与社区获得的肺炎(CAP)管理的免疫活性成年人的指导方针。 推荐不同的治疗方案,具体取决于患者是否在本体或门诊环境中接受治疗,肺炎的严重程度以及患者是否具有可耐药性病原体的可血糖或任何风险因素。患者的推荐抗菌治疗持续时间 帽子至少为5天。 药剂师应积极与医生一起工作,以建议适当的抗微生物治疗治疗帽的患者,并处于关键状态,以确保患者获得适当的治疗持续时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号